Neurovascular Devices Market Was Worth USD 4.2 Billion in 2027, with a 5.8% CAGR

The report analyzes and forecasts the Neurovascular Devices Market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2022 to 2030. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.

The report comprises a detailed value chain analysis, which provides a comprehensive view of the global Neurovascular Devices Market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.

The study provides a decisive view of the Neurovascular Devices Market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

The report provides size (in terms of volume and value) of Neurovascular Devices Market for the base year 2020 and the forecast between 2021 and 2028. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.

Download Sample Report Copy From Here:https://www.acumenresearchandconsulting.com/request-sample/2244

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report. Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding. Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.

Neurovascular Devices Market Market Players as below:

The players profiled in the report are Penumbra, Inc., Boston Scientific Corporation, Microport Scientific Corporation, Merit Medical Systems, Inc., W.L. Gore & Associates, Inc., Stryker Corporation, Medtronic PLC, Johnson & Johnson, Terumo Corporation, and Abbott Laboratories.

The major market segments of Neurovascular Devices Market are as below:

Market By Product

Cerebral Embolization and Aneurysm Coiling Devices

  • Embolic Coils
  • Flow Diverters
  • Liquid Embolic Agents

Cerebral Angioplasty and Stenting Systems

  • Carotid Artery Stents
  • Embolic protection

Neurothrombectomy Devices

  • Clot Retrieval Devices
  • Suction Devices
  • Vascular Snares

Support Devices

  • Micro Catheters
  • Micro Guidewires

Market By Therapeutic Application

Stroke

Cerebral Artery

Cerebral Aneurysm

Others

Ask Query Here: richard@acumenresearchandconsulting.com  or sales@acumenresearchandconsulting.com

Table Of Contents:

Chapter 1. Industry Overview of Neurovascular Devices
1.1 Definition and Scope
1.1.1 Definition of Neurovascular Devices
1.1.2 Market Segmentation
1.1.3 Years Considered for the Study
1.1.4 Assumptions and Acronyms Used
1.1.4.1 Market Assumptions and Market Forecast
1.1.4.2 Acronyms Used In Global Neurovascular Devices Market
1.2 Summary
1.2.1 Executive Summary
1.2.2 Neurovascular Devices Market By Device
1.2.3 Global Neurovascular Devices Market By Therapeutic Applications
1.2.4 Global Neurovascular Devices Market by Regions

Chapter 2. Research Approach
2.1 Methodology
2.1.1 Research Programs/By Resolution Type
2.1.2 Market Size Estimation
2.1.3 Market Breakdown and Data Triangulation
2.2 Data Source
2.2.1 Secondary Sources
2.2.2 Primary Sources

Chapter 3. Market Dynamics and Competition Analysis
3.1 Market Drivers
3.1.1 Driver 1
3.1.2 Driver 2
3.2 Restraints and Challenges
3.2.1 Restraint 1
3.2.2 Restraint 2
3.3 Growth Opportunities
3.3.1 Opportunity 1
3.3.2 Opportunity 2
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Threat of Substitute
3.4.4 Threat of New Entrants
3.4.5 Degree of Competition
3.5 Value Chain Analysis
3.6 Cost Structure Analysis
3.6.1 Proportion of Manufacturing Cost Structure
3.6.1.1 Raw Material
3.6.1.2 Labor Cost
3.6.1.3 Manufacturing Expense
3.7 Regulatory Compliance
3.8 Competitive Landscape, 2019
3.8.1 Player Positioning Analysis
3.8.2 Key Strategies Adopted By Leading Players

Chapter 4. Neurovascular Devices Market By Device
4.1 Introduction
4.2 Global Neurovascular Devices Revenue (US$ Mn) by Device
4.2.1 Global Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Device, 2016 – 2027
4.2.2 Cerebral Embolization and Aneurysm Coiling Devices
4.2.2.1 Cerebral Embolization and Aneurysm Coiling Devices Market Revenue (US$ Mn) and Growth Rate (%), 2016 – 2027
4.2.3 Cerebral Angioplasty and Stenting Systems
4.2.3.1 Cerebral Angioplasty and Stenting Systems Market Revenue (US$ Mn) and Growth Rate (%), 2016 – 2027
4.2.4 Neurothrombectomy Devices
4.2.4.1 Neurothrombectomy Devices Market Revenue (US$ Mn) and Growth Rate (%), 2016 – 2027
4.2.5 Support Devices
4.2.5.1 Support Devices Market Revenue (US$ Mn) and Growth Rate (%), 2016 – 2027
4.3 Market Attractive Analysis By Device 2019

Chapter 5. Neurovascular Devices Market By Therapeutic Applications
5.1 Introduction
5.2 Global Neurovascular Devices Revenue (US$ Mn) by Therapeutic Applications
5.2.1 Global Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Therapeutic Applications, 2016 – 2027
5.2.2 Stroke
5.2.2.1 Stroke Market Revenue (US$ Mn) and Growth Rate (%), 2016 – 2027
5.2.3 Cerebral Artery
5.2.3.1 Cerebral Artery Market Revenue (US$ Mn) and Growth Rate (%), 2016 – 2027
5.2.4 Cerebral Aneurysm
5.2.4.1 Cerebral Aneurysm Market Revenue (US$ Mn) and Growth Rate (%), 2016 – 2027
5.2.5 Others
5.2.5.1 Others Market Revenue (US$ Mn) and Growth Rate (%), 2016 – 2027
5.3 Market Attractive Analysis By Therapeutic Applications 2019

Chapter 6. North America Market By Country
6.1 North America Market Overview
6.2 U.S.
6.2.1 U.S. Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Device, 2016 – 2027
6.2.2 U.S. Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Therapeutic Applications, 2016 – 2027
6.3 Canada
6.3.1 Canada Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Device, 2016 – 2027
6.3.2 Canada Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Therapeutic Applications, 2016 – 2027
6.4 North America PEST Analysis

Chapter 7. Europe Market By Country
7.1 Europe Market Key Overview
7.2 UK
7.2.1 UK Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Device, 2016 – 2027
7.2.2 UK Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Therapeutic Applications, 2016 – 2027
7.3 Germany
7.3.1 Germany Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Device, 2016 – 2027
7.3.2 Germany Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Therapeutic Applications, 2016 – 2027
7.4 France
7.4.1 France Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Device, 2016 – 2027
7.4.2 France Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Therapeutic Applications, 2016 – 2027
7.5 Spain
7.5.1 Spain Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Device, 2016 – 2027
7.5.2 Spain Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Therapeutic Applications, 2016 – 2027
7.6 Rest of Europe
7.6.1 Rest of Europe Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Device, 2016 – 2027
7.6.2 Rest of Europe Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Therapeutic Applications, 2016 – 2027
7.7 Europe PEST Analysis

Chapter 8. Asia-Pacific Market By Country
8.1 Asia Pacific Market Overview
8.2 China
8.2.1 China Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Device, 2016 – 2027
8.2.2 China Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Therapeutic Applications, 2016 – 2027
8.3 Japan
8.3.1 Japan Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Device, 2016 – 2027
8.3.2 Japan Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Therapeutic Applications, 2016 – 2027
8.4 India
8.4.1 India Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Device, 2016 – 2027
8.4.2 India Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Therapeutic Applications, 2016 – 2027
8.5 Australia
8.5.1 Australia Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Device, 2016 – 2027
8.5.2 Australia Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Therapeutic Applications, 2016 – 2027
8.6 South Korea
8.6.1 South Korea Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Device, 2016 – 2027
8.6.2 South Korea Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Therapeutic Applications, 2016 – 2027
8.7 Rest of Asia-Pacific
8.7.1 Rest of Asia Pacific Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Device, 2016 – 2027
8.7.2 Rest of Asia Pacific Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Therapeutic Applications, 2016 – 2027
8.8 Asia Pacific PEST Analysis

Chapter 9. Latin America Market By Country
9.1 Latin America Market Overview
9.2 Brazil
9.2.1 Brazil Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Device, 2016 – 2027
9.2.2 Brazil Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Therapeutic Applications, 2016 – 2027
9.3 Mexico
9.3.1 Mexico Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Device, 2016 – 2027
9.3.2 Mexico Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Therapeutic Applications, 2016 – 2027
9.4 Rest of Latin America
9.4.1 Rest of Latin America Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Device, 2016 – 2027
9.4.2 Rest of Latin America Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Therapeutic Applications, 2016 – 2027
9.5 Latin America PEST Analysis

Chapter 10. Middle East & Africa Market By Country
10.1 Middle East & Africa Market Overview
10.2 Saudi Arabia
10.2.1 Saudi Arabia Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Device, 2016 – 2027
10.2.2 Saudi Arabia Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Therapeutic Applications, 2016 – 2027
10.3 UAE
10.3.1 UAE Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Device, 2016 – 2027
10.3.2 UAE Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Therapeutic Applications, 2016 – 2027
10.4 Rest of Middle East & Africa
10.4.1 Rest of Middle East & Africa Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Device, 2016 – 2027
10.4.2 Rest of Middle East & Africa Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Therapeutic Applications, 2016 – 2027
10.5 Middle East & Africa PEST Analysis

Chapter 11. Player Analysis of Neurovascular Devices
11.1 Global Neurovascular Devices Market Company Share Analysis
11.2 Competition Matrix
11.2.1 Mergers And Acquisition In Global Neurovascular Devices Market

Chapter 12. Company Profile
12.1 Medtronic
12.1.1 Company Snapshot
12.1.2 Business Overview
12.1.3 Financial Overview
12.1.3.1 Revenue (US$ Mn), 2019
12.1.3.2 Medtronic 2019 Neurovascular Devices Business Regional Distribution
12.1.4 Product/Service and Specifications
12.1.5 Manufacturing Plant Footprint Analysis
12.2 Stryker Corporation
12.3 Johnson & Johnson
12.4 Terumo Corporation
12.5 Penumbra, Inc.
12.6 Boston Scientific Corporation
12.7 Microport Scientific Corporation
12.8 W.L. Gore & Associates, Inc.
12.9 Abbott Laboratories
12.10 Others

To Get Premium Report Full Copy in Form of Single user or Multiple user@https://www.acumenresearchandconsulting.com/buy-now/0/2244

About Us:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

Leave a Reply

Your email address will not be published. Required fields are marked *